Avandia, Rosiglitazone Wire
Comprehensive News Feed for Avandia, Rosiglitazone (generic).
Results 1 - 20 of 93 in Avandia, Rosiglitazone (generic)
-
Metformin vs. Sulfonylureas for Diabetes
Dec. 4, 2009 -- Concerns that the diabetes drugs Avandia and Actos raise the risk for heart failure led the FDA to require label changes warning of the potential risk two years ago. Comment?
-
Risk of cardiovascular disease and all cause mortality among patients ...
Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database Export In BMJ, Vol. Comment?
-
To read this article in full you must have registered and have a Premium Content Subscription with the NHS Choices site. Comment?
-
Metformin vs. Sulfonylureas for Diabetes
Dec. 4, 2009 -- Concerns that the diabetes drugs Avandia and Actos raise theA risk for heart failure led the FDA to require label changes warning of the potential risk two years ago. Comment?
-
Study Compares Cardiac, Death Risks of Diabetes Drugs
w/Photo
Use of the sulphonylurea class of drugs for diabetes carries elevated risks of cardiac and all-cause death, while among drugs in the thiazolidinedione class, pioglitazone posed the lowest risk, according to an analysis published online Dec. Comment?
-
Oral Diabetes Drugs and CVD Risk
An assessment of "real world" use of oral agents for type 2 diabetes shows significant risk differences among drug classes, BMJ reports. Comment?
-
Statin and Diabetes Drug Show Activity against Hepatitis B Virus in Laboratory Studies
SUMMARY: Simvastatin , a medication used to lower blood cholesterol, had a synergistic effect against hepatitis B virus when combined with antiviral drugs in a laboratory study, researchers reported last month at the 60th Annual Meeting of the American Association for the Study of Liver Diseases in Boston. Comment?
-
Adiponectin. An Indispensable Molecule in Rosiglitazone...
Lingtao2006{at}gmail.com or Xin.Ma{at}Jefferson.edu . Rationale : Patients treated with peroxisome proliferator-activated receptor - agonist manifest favorable metabolic profiles associated with increased plasma adiponectin . Comment?
-
Commercial Insight: Antidiabetics In Australia - Reimbursement Status ...
w/Photo
Commercial Insight: Antidiabetics In Australia - Reimbursement Status Shapes Novel Classes - New Report Published Introduction The Australian antidiabetics market is expected to reach $416m by 2018. Comment?
-
Advances in the Treatment of Type 2 Diabetes Mellitus.
Search all the public and authenticated articles in CiteULike. Enter a search phrase. Comment?
-
Commercial Insight: Antidiabetics in Australia - Reimbursement status ...
w/Photo
Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes - new report released companiesandmarkets.com companiesandmarkets.com 2009-11-26 20:05:08 - Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes - a new market research report on companiesandmarkets.com ... Comment?
-
PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte...
C-Met/HGF/SF signaling is essential for normal embryogenesis, organogenesis, and tissue regeneration. Comment?
-
New research: Commercial Insight: Antidiabetics - DPP-IV inhibitors poised to sweep the market
The growth will be driven by the launch of new drug classes, notably the DPP-IV inhibitors and GLP-1 agonists, and large growth in patient numbers. Comment?
-
Diabetes drugs double women's fracture risk
Long-term use of GlaxoSmithKline's Avandia and Takeda's Actos doubles the risk of bone fractures in women with type 2 diabetes, according to a study released on Wednesday. Comment?
-
Study links diabetes drug to heart failure
A diabetes drug used by tens of thousands of Canadians increases the risk of heart attack, heart failure and death in older patients, concludes a vast new Ontario study that suggests Avandia's dangers may often outweigh its benefits. Comment?
-
Oral-lyn vs. Afresa: How Generex Will Beat Mannkind
As biotech companies and large pharma embark on paths to usher in more effective diabetes drugs to market, one of the more significant concerns regarding diabetes related drug development is safety. Comment?
-
Thiazolidinediones Reduce Pathological Neovascularization in Ischemic ...
From the Molecular Cardiology/Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Mass ; and the Department of Cardiology, Nagoya University Graduate School of Medicine, Japan . Comment?
-
Diabetes drug could lead to heart failure: Study
New research involving nearly 40,000 Ontario patients is questioning the use of a widely prescribed diabetes drug that an expert in drug safety says should be removed from the market Photograph by: Bill Keay, Vancouver Sun New research involving nearly 40,000 Ontario patients is questioning the use of a widely prescribed diabetes drug that an ... Comment?
-
Research and Markets: Commercial Insight: Antidiabetics in Australia...
Research and Markets: Commercial Insight: Antidiabetics in Australia - Reimbursement Status Shapes Novel Classes Datamonitor expects the Australian antidiabetics market to reach $416m by 2018. Comment?
-
Early diabetes treatment key for long term health: study
People with diabetes given intensive drug treatment soon after diagnosis are healthier when they grow older, even if they become less rigorous about controlling their blood sugar later on, British researchers said on Wednesday. Comment?
Avandia, Rosiglitazone Forum
Most Popular
- Farrakhan: America's time is up - 252 comments
- GALLUP: OBAMA HITS NEW LOW AT 47%. - 442 comments
- Transgender teen: McDonald's refused to hire me - 357 comments
- Tiger Woods alienates black community with white lovers? Garbage - 137 comments
- Report Says Tiger's Wife Has moved Out of House & Mistress Count Up to 9 - 144 comments
- Presiden Indonesia Merasa Akan Dijatuhkan - 124 comments
- Man arrested for throwing a tomato at Sarah Palin during Mall of America 'Goi... - 109 comments
- Where did all the warming go? - 120 comments
- Claiming Macedonia - 151 comments
- Man accused of setting fire to dog in Stratford - 112 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
